Comprehensive Management for the Treatment of Obstructive Sleep Apnea
SLEEP APNEA SYNDROME
About this trial
This is an interventional treatment trial for SLEEP APNEA SYNDROME focused on measuring SLEEP, APNEA, EXERCISE
Eligibility Criteria
Inclusion Criteria:
- Moderate to severe Obstructive Sleep Apnea Hypopnea Syndrome (AHI > 15/h)
Exclusion Criteria:
- BMI > 40
- Concomitant heart disease, stroke or severe neuromuscular with medical judgment not doing exercise.
- Musculoskeletal disorders that impede the realization of the exercises
- Sleepiness affects your physical or occupational functioning.
Sites / Locations
- Hospital Clinic de Barcelona
Arms of the Study
Arm 1
Arm 2
Experimental
Sham Comparator
Interventional group
Control Group
Participants followed a 8-week intervention program with a total of 24 sessions (12 of those were supervised). The aim of the supervision was to increase the adherence to the treatment and to control the compliance of patients. General physical activity consisted in walking along previously standardized urban parks designed for the urban EPOC training project (Arbillaga-Etxarri et al, 2016). The duration of walking were 30 minutes. The physiotherapist supervised the accomplishment of other activities such as oropharyngeal exercises and diet control. Oropharyngeal exercises: Expiratory muscle strength training (EMST): Masako Manoeuvre Shaker Head Lift: Facial exercise
Control group participants only received general recommendations regarding general physical activity, diet and sleep hygiene. After 8-weeks of control, they were re-evaluated with the same evaluation test used in the beginning of the study period. Recommendations for general physical activity were walking during 30 minutes at least 3 times a week maintaining the greatest possible pace. Also, control group patients received the same diet control document as intervention group and verbal advice for sleep hygiene. Approximately 1 month after enrolment, a follow-up phone call was completed were we also informed about the new re-evaluation data.